5th Circuit Temporarily Halts Abortion-By-Mail Scheme
Saturday, May 2 2026 - Permalink
CourtsThe U.S. Court of Appeals for the 5th Circuit ruled that the U.S. Food and Drug Administration must restore the in-person dispensing requirement for the abortion drug mifepristone pending appeal. This ruling prevents pro-abortion activists and doctors from mailing streams of high-risk abortion drugs into states that protect the lives of unborn babies. In the case State of Louisiana v. U.S. Food and Drug Administration, Louisiana Attorney General Liz Murrill and attorneys with Alliance Defending Freedom asked the court to temporarily block the unlawful mailing of abortion drugs into pro-life states while the 5th Circuit considers Louisiana's appeal from the district court's denial of preliminary relief. Read more...

